Thomas Cooper Woods

Title: Thomas Cooper Woods: Innovator in Carotid Artery Disease Research

Introduction

Thomas Cooper Woods is a notable inventor based in New Orleans, LA (US). He has made significant contributions to the field of medical research, particularly in the detection and treatment of carotid artery diseases. With a total of 6 patents to his name, Woods has developed innovative methods that aim to improve patient outcomes.

Latest Patents

Woods' latest patents include groundbreaking methods for detecting, diagnosing, and treating carotid plaque vulnerability. These methods utilize levels of Resolvin D1 (RvD1), docosahexaenoic acid (DHA), and arachidonic acid (AA) to identify vulnerable carotid artery disease that may become acutely symptomatic. Additionally, he has developed methods for treating carotid artery disease and identifying agents for its treatment. Another significant patent focuses on detecting and diagnosing atherosclerotic plaque rupture. This involves the expression of miR-222, miR-221, and circ284, along with methods for treating arterial plaque rupture and identifying relevant agents.

Career Highlights

Throughout his career, Woods has worked with reputable institutions, including the Ochsner Clinic Foundation. His work has been instrumental in advancing the understanding and treatment of carotid artery diseases, showcasing his commitment to medical innovation.

Collaborations

Woods has collaborated with notable professionals in his field, including Corey Keith Goldman and Hernan Bazan. These partnerships have further enhanced his research and development efforts.

Conclusion

Thomas Cooper Woods stands out as a dedicated inventor whose work in carotid artery disease research has the potential to significantly impact patient care. His innovative patents and collaborations reflect his commitment to advancing medical science.